Vyome Holdings (HIND) completes merger and asset sale, appoints new CEO and board

Vyome Holdings, Inc

Merger closed: Vyome Therapeutics becomes subsidiary; company renamed Vyome Holdings, Inc.
Asset sale: ReShape sold its assets to Biorad for $2.25M cash, assuming substantially all liabilities.
Reverse stock split: 1-for-4 split effective Aug 15, 2025 to meet Nasdaq minimum bid price.
Leadership: New CEO Venkateswarlu Nelabhotla, interim CFO Robert Dickey; six new directors appointed.
Equity sale: 529,137 shares sold at $11.02 per share in unregistered offering post-merger.

item 2.01item 3.02item 3.03item 5.02item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.